Cargando…

An aging‐related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma

Aging has been demonstrated to play vital roles in the prognosis and treatment efficacy of cancers, including lung adenocarcinoma (LUAD). This novel study aimed to construct an aging‐related risk signature to evaluate the prognosis and immunogenicity of LUAD. Transcriptomic profiles and clinical inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenjing, Li, Yuting, Lyu, Juncheng, Shi, Fuyan, Kong, Yujia, Sheng, Chao, Wang, Suzhen, Wang, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898732/ https://www.ncbi.nlm.nih.gov/pubmed/34967077 http://dx.doi.org/10.1111/cas.15254

Ejemplares similares

Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
por: Zhang, Wenjing, et al.
Publicado: (2022)

Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations
por: Zhang, Wenjing, et al.
Publicado: (2022)

Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
por: Zhang, Wenjing, et al.
Publicado: (2021)

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer
por: Zhang, Wenjing, et al.
Publicado: (2022)

Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients
por: Wang, Qinghua, et al.
Publicado: (2022)

Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma
por: Wang, Qinghua, et al.
Publicado: (2021)

Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins
por: Qi, Xiao, et al.
Publicado: (2023)

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma
por: Givechian, Kevin B., et al.
Publicado: (2019)

Identification and Validation of RELN Mutation as a Response Indicator for Immune Checkpoint Inhibitor Therapy in Melanoma and Non-Small Cell Lung Cancer
por: Li, Zhenpeng, et al.
Publicado: (2022)

Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
por: Shi, Fuyan, et al.
Publicado: (2021)

SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC
por: An, Fengxiao, et al.
Publicado: (2023)

Assessing the Survival Benefit of Surgery and Various Types of Radiation Therapy for Treatment of Hepatocellular Carcinoma: Evidence from the Surveillance, Epidemiology, and End Results Registries
por: Shi, Fuyan, et al.
Publicado: (2020)

Ensemble Learning to Improve the Prediction of Fetal Macrosomia and Large-for-Gestational Age
por: Ye, Shangyuan, et al.
Publicado: (2020)

Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort
por: Zhang, Wenjing, et al.
Publicado: (2021)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung
por: He, Si-Yu, et al.
Publicado: (2019)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma
por: Wang, Qinghua, et al.
Publicado: (2021)

Systematic profiling of invasion‐related gene signature predicts prognostic features of lung adenocarcinoma
por: Yu, Ping, et al.
Publicado: (2021)

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
por: Wang, Jiao, et al.
Publicado: (2020)

Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2020)

Epidemic of chronic diseases and the related healthy lifestyle interventions in rural areas of Shandong Province, China
por: Lyu, Juncheng, et al.
Publicado: (2020)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

High expression of CD8 predicts favorable prognosis in patients with lung adenocarcinoma: A cohort study
por: Ye, Sheng-Lan, et al.
Publicado: (2017)

Identification of immunogenic cell death‑related prognostic signatures in pancreatic cancer
por: Yu, Wenjing, et al.
Publicado: (2023)

Identification of metabolism-related gene signature in lung adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2023)

High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma
por: Han, Fei, et al.
Publicado: (2015)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Autophagy-Related Gene Signature Highlights Metabolic and Immunogenic Status of Malignant Cells in Non-Small Cell Lung Cancer Adenocarcinoma
por: Leonardi, Lucas, et al.
Publicado: (2022)

Prognostic signature of lung adenocarcinoma based on stem cell-related genes
por: Huang, Zhanghao, et al.
Publicado: (2021)

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma
por: Wang, Qinyang, et al.
Publicado: (2022)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2022)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

An individualized gene expression signature for prediction of lung adenocarcinoma metastases
por: Qi, Lishuang, et al.
Publicado: (2017)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis
por: Hong, Chunhong, et al.
Publicado: (2021)

Toxins Secreted by Bacillus Isolated from Lung Adenocarcinomas Favor the Penetration of Toxic Substances
por: Merlos, Alexandra, et al.
Publicado: (2015)

TOX3 is a favorable prognostic indicator and potential immunomodulatory factor in lung adenocarcinoma
por: Zeng, De, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c8cul2mqsuogo7b4kps823pogv